Yorke Justin W 4
4 · Processa Pharmaceuticals, Inc. · Filed Jan 31, 2024
Insider Transaction Report
Form 4
Yorke Justin W
Director
Transactions
- Purchase
Common Stock
2024-01-30$2.69/sh+8,000$21,544→ 31,232 total(indirect: By LLC)
Holdings
- 3,737
Common Stock
Footnotes (1)
- [F1]Effective on January 22, 2024, Processa Pharmaceuticals, Inc. effected a 20 to 1 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.